Correlation Between Kura Oncology and Alvotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kura Oncology and Alvotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kura Oncology and Alvotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kura Oncology and Alvotech, you can compare the effects of market volatilities on Kura Oncology and Alvotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kura Oncology with a short position of Alvotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kura Oncology and Alvotech.

Diversification Opportunities for Kura Oncology and Alvotech

-0.48
  Correlation Coefficient

Very good diversification

The 3 months correlation between Kura and Alvotech is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Kura Oncology and Alvotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alvotech and Kura Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kura Oncology are associated (or correlated) with Alvotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alvotech has no effect on the direction of Kura Oncology i.e., Kura Oncology and Alvotech go up and down completely randomly.

Pair Corralation between Kura Oncology and Alvotech

Given the investment horizon of 90 days Kura Oncology is expected to generate 2.32 times more return on investment than Alvotech. However, Kura Oncology is 2.32 times more volatile than Alvotech. It trades about 0.21 of its potential returns per unit of risk. Alvotech is currently generating about -0.07 per unit of risk. If you would invest  726.00  in Kura Oncology on November 18, 2024 and sell it today you would earn a total of  102.00  from holding Kura Oncology or generate 14.05% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Kura Oncology  vs.  Alvotech

 Performance 
       Timeline  
Kura Oncology 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Kura Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Alvotech 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Alvotech are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Alvotech may actually be approaching a critical reversion point that can send shares even higher in March 2025.

Kura Oncology and Alvotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kura Oncology and Alvotech

The main advantage of trading using opposite Kura Oncology and Alvotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kura Oncology position performs unexpectedly, Alvotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alvotech will offset losses from the drop in Alvotech's long position.
The idea behind Kura Oncology and Alvotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Complementary Tools

Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk